Agilent Technologies Inc. reported net revenue of USD 7.0 billion for the full year ended October 31, 2025, marking a 7 percent increase. Growth was driven across all segments, geographic regions, and most key end markets. Product revenue rose 6 percent, primarily supported by increases in contract development and manufacturing. The Agilent CrossLab segment posted revenue of USD 2.9 billion, up 6 percent for the period, with growth attributed to strength in repair, maintenance, compliance services, lab automation, and consumables. Revenue from the BIOVECTRA acquisition contributed approximately 2 percentage points to overall revenue growth for the year. The company previously registered a 5 percent year-over-year decline in net revenue for the full year ended October 31, 2024. Foreign currency movements had no impact on revenue growth for the year ended October 31, 2025.